Literature DB >> 1659158

Protective effect of vitamin D3 analogues on endotoxin shock in mice.

H Horiuchi1, I Nagata, K Komoriya.   

Abstract

The effect of vitamin D3 analogues on endotoxin shock in mice was investigated. Male ICR mice were orally administered vitamin D3 analogues or vehicle, accompanied by an intraperitoneal injection of endotoxin (E. Coli lipopolysaccharide, LPS, 20 mg/kg). Endotoxin caused a decrease in survival rate in a time-dependent manner. Increases in plasma immunoreactive (i) eicosanoid and hepatic malondialdehyde (MDA) levels were also observed. Administration of 1 alpha-hydroxyvitamin D3 (1 alpha-OH-D3) improved the survival rate 24 to 48 h after endotoxin treatment. The effects were markedly observed at a dose of 20 ng/kg. In addition, 1 alpha-OH-D3 restored the plasma iTXB2 and hepatic MDA levels 8 h after endotoxin injection. However, it did not affect plasma iPGE2, i6-keto-PGF1 alpha and blood iLTB4 levels. At a dose of 20 ng/kg, both 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) and 1,24(R)-dihydroxyvitamin D3 (1,24(R)-(OH)2D3) restored the survival rate, the plasma iTXB2 and hepatic MDA levels. These results suggest that vitamin D3 analogues may inhibit endotoxemia through regulation of the formation of TXA2 and free radicals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659158     DOI: 10.1007/bf01986584

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  30 in total

1.  Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver.

Authors:  M Fukushima; Y Suzuki; Y Toira; I Matsunaga; K Ochi; H Nagano
Journal:  Biochem Biophys Res Commun       Date:  1975-09-16       Impact factor: 3.575

2.  1,25-Dihydroxyvitamin D3 maintains adherence of human monocytes and protects them from thermal injury.

Authors:  B S Polla; A M Healy; E P Amento; S M Krane
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

3.  1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells.

Authors:  C Miyaura; E Abe; T Kuribayashi; H Tanaka; K Konno; Y Nishii; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1981-10-15       Impact factor: 3.575

4.  Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes.

Authors:  K Matsumoto; K Hashimoto; M Kiyoki; M Yamamoto; K Yoshikawa
Journal:  J Dermatol       Date:  1990-02       Impact factor: 4.005

5.  Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action.

Authors:  W Hagmann; C Denzlinger; D Keppler
Journal:  Circ Shock       Date:  1984

6.  The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants.

Authors:  K Sugino; K Dohi; K Yamada; T Kawasaki
Journal:  Surgery       Date:  1987-06       Impact factor: 3.982

7.  Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production.

Authors:  A K Bhalla; E P Amento; S M Krane
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

8.  Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.

Authors:  H P Koeffler; T Amatruda; N Ikekawa; Y Kobayashi; H F DeLuca
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

9.  Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol.

Authors:  I Olsson; U Gullberg; I Ivhed; K Nilsson
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

10.  Endotoxin-induced eicosanoid production by equine vascular endothelial cells and neutrophils.

Authors:  G D Bottoms; M A Johnson; C H Lamar; J F Fessler; J J Turek
Journal:  Circ Shock       Date:  1985
View more
  15 in total

Review 1.  Toll-like receptor 4 modulation as a strategy to treat sepsis.

Authors:  X Wittebole; D Castanares-Zapatero; P F Laterre
Journal:  Mediators Inflamm       Date:  2010-04-14       Impact factor: 4.711

2.  Association between prehospital vitamin D status and hospital-acquired bloodstream infections.

Authors:  Sadeq A Quraishi; Augusto A Litonjua; Takuhiro Moromizato; Fiona K Gibbons; Carlos A Camargo; Edward Giovannucci; Kenneth B Christopher
Journal:  Am J Clin Nutr       Date:  2013-08-14       Impact factor: 7.045

Review 3.  Micronutrients in Sepsis and COVID-19: A Narrative Review on What We Have Learned and What We Want to Know in Future Trials.

Authors:  Matteo Rossetti; Gennaro Martucci; Christina Starchl; Karin Amrein
Journal:  Medicina (Kaunas)       Date:  2021-04-26       Impact factor: 2.430

Review 4.  Vitamin D in sepsis: from basic science to clinical impact.

Authors:  Jordan A Kempker; Vin Tangpricha; Thomas R Ziegler; Greg S Martin
Journal:  Crit Care       Date:  2012-07-19       Impact factor: 9.097

5.  Serum 1,25-dihydroxyvitamin D: an outcome prognosticator in human sepsis.

Authors:  H Bryant Nguyen; Blen Eshete; K H William Lau; Adarsh Sai; Mark Villarin; David Baylink
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

6.  Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity.

Authors:  Mathias W Pletz; Christoph Terkamp; Ulrike Schumacher; Gernot Rohde; Hartwig Schütte; Tobias Welte; Robert Bals
Journal:  Respir Res       Date:  2014-04-27

7.  Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice.

Authors:  Marija Djukic; Nadine Sostmann; Thomas Bertsch; Marianne Mecke; Stefan Nessler; Anja Manig; Uwe-Karsten Hanisch; Jakob Triebel; L Cornelius Bollheimer; Cornel Sieber; Roland Nau
Journal:  J Neuroinflammation       Date:  2015-01-07       Impact factor: 8.322

8.  Vitamin D and sepsis: An emerging relationship.

Authors:  Jordan A Kempker; Jenny E Han; Vin Tangpricha; Thomas R Ziegler; Greg S Martin
Journal:  Dermatoendocrinol       Date:  2012-04-01

9.  Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis.

Authors:  Søren Møller; Finn Laigaard; Klaus Olgaard; Claus Hemmingsen
Journal:  Int J Med Sci       Date:  2007-07-10       Impact factor: 3.738

10.  Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients.

Authors:  Bisundev Mahato; Tiffany M N Otero; Carrie A Holland; Patrick T Giguere; Ednan K Bajwa; Carlos A Camargo; Sadeq A Quraishi
Journal:  J Intensive Care       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.